NMS · Biotechnology

ANAB (ANAB) Stock

$53.61 -1.00% NMS: ANAB Healthcare

Valuation

MetricValue
Price$53.61
Market Cap$2.31B
P/E Ratio-127.70
P/B Ratio68.46
P/S Ratio10.90
EPS (TTM)$-0.46
52-Week High$69.81
52-Week Low$11.40
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-35.14%
ROA-3.57%
ROCE129.73%
Gross Margin20.43%
Operating Margin20.43%
Net Margin-11.53%
Debt/Equity21.76
Current Ratio8.97

Annual Financials (USD)

Metric20212022202320242025
Revenue$63.0M$10.0M$17.0M$91.0M$235.0M
Operating Profit$-57.0M$-115.0M$-164.0M$-115.0M$48.0M
Net Profit$-58.0M$-129.0M$-164.0M$-145.0M$-13.0M
EPS$-2.11$-4.57$-6.08$-5.12$-0.46
Op Margin-89.9%-1119.4%-958.3%-125.9%20.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$643.0M$610.0M$452.0M$484.0M$364.0M
Total Liabilities$287.0M$348.0M$364.0M$413.0M$327.0M
Cash$496.0M$71.0M$36.0M$123.0M$238.0M
Borrowings$21.0M$19.0M$18.0M$369.0M$14.0M

Latest News

What Makes AnaptysBio (ANAB) an Investment Bet? Insider Monkey · Jul 14, 2026 Is AnaptysBio (ANAB) Outperforming Other Medical Stocks This Year? Zacks · May 21, 2026 Wall Street Analysts See a 38.75% Upside in AnaptysBio (ANAB): Can the Stock Really Move This High? Zacks · May 19, 2026 How The Grupo Traxión (BMV:TRAXION A) Story Is Shifting With Cautious New Analyst Targets Simply Wall St. · May 15, 2026 AnaptysBio (ANAB) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now Zacks · May 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-46.0M$-74.0M$-121.0M$-135.0M$20.0M
Investing Cash Flow$37.0M$-395.0M$144.0M$95.0M$228.0M
Financing Cash Flow$250.0M$32.0M$-50.0M$-9.0M$-70.0M
Net Cash Flow$245.0M$-424.0M$-35.0M$87.0M$115.0M
Free Cash Flow$-47.0M$-74.0M$-122.0M$-136.0M$20.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA46.18
FCF Yield0.17%
Quick Ratio7.58
Interest Coverage0.60
Return 1Y201.09%
Return 3Y335.51%
Return 5Y206.47%

Ownership

Insiders Held5.68%
Institutions Held101.74%
Institutions Float Held107.86%
Institutional HolderSharesReport Date
EcoR1 Capital, LLC7,880,0942026-03-31
Blackrock Inc.1,681,3802026-03-31
Tang Capital Management, LLC1,330,8792026-03-31
Morgan Stanley993,9052026-03-31
State Street Corporation992,4452026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BBOT $8.09 -4.82% -3.62 $648.07M 0.00%
DNTH $104.09 +2.44% -17.99 $4.35B 0.00%
KOD $41.58 -2.16% -8.11 $2.60B 0.00%
MNMDMind Medicine (MindMed) Inc. $20.69 +0.44% -18.83 $1.56B 0.00%
NRIX $24.11 -0.17% -6.41 $2.50B 0.00%

About ANAB

ANAB stock trades at $53.61 with a market capitalization of $2.31B. The stock is valued at a price-to-earnings (P/E) ratio of -127.70, price-to-book of 68.46, price-to-sales of 10.90. Over the past 52 weeks the stock has ranged between $11.40 and $69.81, and currently trades 23.2% below its 52-week high.

On profitability, ANAB generates a return on equity (ROE) of -35.14%, return on capital employed of 129.73%, an operating margin of 20.43%, a net profit margin of -11.53%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides